Nanomaterials in personalized medicine market to reach $674.28 billion by 2030 at 11.3% cagr, driven by increasing demand for personalized medicine and targeted therapeutic solutions.
Read More
Nanocarriers market to reach $26.74 billion by 2030 at 18.1% cagr, driven by rising demand for personalized medicines and advanced drug delivery technologies.
Read More
Naloxone spray market to reach $2428.63 billion by 2030 at 24.6% cagr, driven by increasing demand for telemedicine and rapid response to opioid overdose cases.
Read More
Myeloproliferative disorders drugs market to reach $12.17 billion by 2030 at 4.6% cagr, driven by rise in incidence of myeloproliferative disorders and aging population.
Read More
Myelodysplastic syndrome drugs market to reach $3.84 billion by 2030 at 9.6% cagr, driven by rising demand for personalized medicine and genomics-based treatment approaches.
Read More
Myc proto oncogene protein market to reach $3.44 billion by 2030 at 12.6% cagr, driven by increasing number of clinical trials and rising prevalence of cancer globally.
Read More
Mutation detection kits in genome editing market to reach $2.1 billion by 2030 at 13.0% cagr, driven by rising prevalence of genetic disorders and need for precise genomic analysis.
Read More
Muscle relaxant drugs market to reach $7.43 billion by 2030 at 7.8% cagr, driven by increasing number of sports injuries and rising cases of musculoskeletal disorders.
Read More
Multivitamin capsules and tablets market to reach $40.6 billion by 2030 at 6.2% cagr, driven by increasing health consciousness among individuals and demand for preventive nutrition.
Read More
Multivalent vaccines market to reach $14.28 billion by 2030 at 9.4% cagr, driven by rising incidences of infectious diseases and increasing focus on broad-spectrum immunization.
Read More